Illustrative image – not actual.The Chatterjee Group is reportedly planning to set up a
globally-compatible genome valley in Delhi and has sought the government’s
approval for the same.
The group has a presence in drug research at present
through ChemBiotech Research, which supports R&D of pharmaceutical
companies in areas such as molecular medicine and bio-informatics.
The proposal by Chatterjee Management Services (CMS) was
approved in principle by the Department of Science & Technology’s screening
committee in June 2002. The Department is expected to fund up to 50 per cent of
the total project cost under its drugs & pharmaceutical research programme.
The genome valley project would be supported by the Council
of Scientific & Industrial Research, which would allot the required land and
lend technical and human resource support.
The first phase of the project is to be completed in one year at a cost of Rs.25 crore. The proposed genome valley will be designed to deliver a comprehensive package of services to pharmaceutical companies desirous of augmenting their R&D using tools of genomics. It will have instrumentation facilities for a slew of genomic projects like mapping of genes and pharmacogenomics.
